251 related articles for article (PubMed ID: 24612202)
1. Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses study.
Vandell AG; McDonough CW; Gong Y; Langaee TY; Lucas AM; Chapman AB; Gums JG; Beitelshees AL; Bailey KR; Johnson RJ; Boerwinkle E; Turner ST; Cooper-DeHoff RM; Johnson JA
J Intern Med; 2014 Nov; 276(5):486-97. PubMed ID: 24612202
[TBL] [Abstract][Full Text] [Related]
2. Genome Wide Analysis Approach Suggests Chromosome 2 Locus to be Associated with Thiazide and Thiazide Like-Diuretics Blood Pressure Response.
Singh S; McDonough CW; Gong Y; Bailey KR; Boerwinkle E; Chapman AB; Gums JG; Turner ST; Cooper-DeHoff RM; Johnson JA
Sci Rep; 2019 Nov; 9(1):17323. PubMed ID: 31754133
[TBL] [Abstract][Full Text] [Related]
3. Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression.
Duarte JD; Turner ST; Tran B; Chapman AB; Bailey KR; Gong Y; Gums JG; Langaee TY; Beitelshees AL; Cooper-Dehoff RM; Boerwinkle E; Johnson JA
Pharmacogenomics J; 2013 Jun; 13(3):257-63. PubMed ID: 22350108
[TBL] [Abstract][Full Text] [Related]
4. Genome Wide Association Study Identifies the
Singh S; McDonough CW; Gong Y; Alghamdi WA; Arwood MJ; Bargal SA; Dumeny L; Li WY; Mehanna M; Stockard B; Yang G; de Oliveira FA; Fredette NC; Shahin MH; Bailey KR; Beitelshees AL; Boerwinkle E; Chapman AB; Gums JG; Turner ST; Cooper-DeHoff RM; Johnson JA
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29523524
[TBL] [Abstract][Full Text] [Related]
5. Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide.
Moore MJ; Gong Y; Hou W; Hall K; Schmidt SO; Curry RW; Beitelshees AL; Chapman A; Turner ST; Schwartz GL; Bailey K; Boerwinkle E; Gums JG; Cooper-DeHoff RM; Johnson JA
Pharmacotherapy; 2014 Nov; 34(11):1132-40. PubMed ID: 25202885
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
Del-Aguila JL; Beitelshees AL; Cooper-Dehoff RM; Chapman AB; Gums JG; Bailey K; Gong Y; Turner ST; Johnson JA; Boerwinkle E
Pharmacogenomics J; 2014 Feb; 14(1):35-40. PubMed ID: 23400010
[TBL] [Abstract][Full Text] [Related]
7. PROX1 gene variant is associated with fasting glucose change after antihypertensive treatment.
Gong Y; McDonough CW; Beitelshees AL; Karnes JH; O'Connell JR; Turner ST; Chapman AB; Gums JG; Bailey KR; Boerwinkle E; Johnson JA; Cooper-DeHoff RM
Pharmacotherapy; 2014 Feb; 34(2):123-30. PubMed ID: 24122840
[TBL] [Abstract][Full Text] [Related]
8. Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.
McDonough CW; Gillis NK; Alsultan A; Chang SW; Kawaguchi-Suzuki M; Lang JE; Shahin MH; Buford TW; El Rouby NM; Sá AC; Langaee TY; Gums JG; Chapman AB; Cooper-DeHoff RM; Turner ST; Gong Y; Johnson JA
PLoS One; 2013; 8(10):e76984. PubMed ID: 24116192
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension.
Flack JM; Saunders E; Gradman A; Kraus WE; Lester FM; Pratt JH; Alderman M; Green S; Vargas R; Espenshade M; Ceesay P; Alexander J; Goldberg A;
Clin Ther; 2001 Aug; 23(8):1193-208. PubMed ID: 11558858
[TBL] [Abstract][Full Text] [Related]
10. Impact of TCF7L2 single nucleotide polymorphisms on hydrochlorothiazide-induced diabetes.
Karnes JH; Gong Y; Pacanowski MA; McDonough CW; Arwood MJ; Langaee TY; Pepine CJ; Johnson JA; Cooper-Dehoff RM
Pharmacogenet Genomics; 2013 Dec; 23(12):697-705. PubMed ID: 24128935
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure Response.
Shahin MH; Sá AC; Webb A; Gong Y; Langaee T; McDonough CW; Riva A; Beitleshees AL; Chapman AB; Gums JG; Turner ST; Boerwinkle E; Scherer SE; Sadee W; Cooper-DeHoff RM; Johnson JA
Circ Cardiovasc Genet; 2017 Jan; 10(1):. PubMed ID: 28115488
[TBL] [Abstract][Full Text] [Related]
12. Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses).
McDonough CW; Magvanjav O; Sá ACC; El Rouby NM; Dave C; Deitchman AN; Kawaguchi-Suzuki M; Mei W; Shen Y; Singh RSP; Solayman M; Bailey KR; Boerwinkle E; Chapman AB; Gums JG; Webb A; Scherer SE; Sadee W; Turner ST; Cooper-DeHoff RM; Gong Y; Johnson JA
Circ Genom Precis Med; 2018 Apr; 11(4):e001854. PubMed ID: 29650764
[TBL] [Abstract][Full Text] [Related]
13. Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide.
Duarte JD; Zineh I; Burkley B; Gong Y; Langaee TY; Turner ST; Chapman AB; Boerwinkle E; Gums JG; Cooper-Dehoff RM; Beitelshees AL; Bailey KR; Fillingim RB; Kone BC; Johnson JA
J Transl Med; 2012 Mar; 10():56. PubMed ID: 22440088
[TBL] [Abstract][Full Text] [Related]
14. Race-Specific Comparisons of Antihypertensive and Metabolic Effects of Hydrochlorothiazide and Chlorthalidone.
Chekka LMS; Chapman AB; Gums JG; Cooper-DeHoff RM; Johnson JA
Am J Med; 2021 Jul; 134(7):918-925.e2. PubMed ID: 33434556
[TBL] [Abstract][Full Text] [Related]
15. Effect of hydrochlorothiazide on serum uric acid concentration: a genome-wide association study.
Ala-Mutka EM; Rimpelä JM; Fyhrquist F; Kontula KK; Hiltunen TP
Pharmacogenomics; 2018 Apr; 19(6):517-527. PubMed ID: 29580174
[TBL] [Abstract][Full Text] [Related]
16. Reversal of an unfavorable effect of hydrochlorothiazide compared to angiotensin converting enzyme inhibitor on serum uric acid and oxypurine levels by estrogen-progestin therapy in hypertensive postmenopausal women.
Posadzy-Malaczynska A; Rajpold K; Woznicka-Leskiewicz L; Marcinkowska J
Curr Med Res Opin; 2019 Oct; 35(10):1687-1697. PubMed ID: 31033362
[No Abstract] [Full Text] [Related]
17. Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension phase.
Sica D; Gradman AH; Lederballe O; Kolloch RE; Zhang J; Keefe DL
Clin Drug Investig; 2011 Dec; 31(12):825-37. PubMed ID: 22035463
[TBL] [Abstract][Full Text] [Related]
18. Genome-Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β-Blockers.
Shahin MH; Conrado DJ; Gonzalez D; Gong Y; Lobmeyer MT; Beitelshees AL; Boerwinkle E; Gums JG; Chapman A; Turner ST; Cooper-DeHoff RM; Johnson JA
J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478026
[TBL] [Abstract][Full Text] [Related]
19. Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.
Gong Y; McDonough CW; Wang Z; Hou W; Cooper-DeHoff RM; Langaee TY; Beitelshees AL; Chapman AB; Gums JG; Bailey KR; Boerwinkle E; Turner ST; Johnson JA
Circ Cardiovasc Genet; 2012 Dec; 5(6):686-91. PubMed ID: 23087401
[TBL] [Abstract][Full Text] [Related]
20. A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics Integration.
Shahin MH; Gong Y; McDonough CW; Rotroff DM; Beitelshees AL; Garrett TJ; Gums JG; Motsinger-Reif A; Chapman AB; Turner ST; Boerwinkle E; Frye RF; Fiehn O; Cooper-DeHoff RM; Kaddurah-Daouk R; Johnson JA
Hypertension; 2016 Sep; 68(3):621-9. PubMed ID: 27381900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
